{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:57:28Z","timestamp":1791068248892,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001870","type":"journal-article","created":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T17:14:45Z","timestamp":1351790085000},"page":"e1870","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":152,"title":["Fexinidazole: A Potential New Drug Candidate for Chagas Disease"],"prefix":"10.1371","volume":"6","author":[{"given":"Maria Terezinha","family":"Bahia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Mayer de","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassiane Ass\u00edria Fontes","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro Fernando da Silva do","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia de Figueiredo","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo Santana","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Talvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette Bourdin","family":"Trunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Torreele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2010) Media centre. Chagas disease (American trypanosomiasis). Fact sheet N\u00b0340, June 2010."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/648073","article-title":"New advances in the management of a long-neglected disease","volume":"49","author":"JA Urbina","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.01742-09","article-title":"Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with <italic>Trypanosoma cruzi<\/italic>","volume":"54","author":"LF Diniz","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1128\/AAC.48.11.4286-4292.2004","article-title":"Activity of the new triazole derivative albaconazole against <italic>Trypanosoma (Schizotrypanum) cruzi<\/italic> in dog hosts","volume":"48","author":"PM Guedes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.47.1.223-230.2003","article-title":"Chemotherapy with Benznidazole and Itraconazole for mice infected with different <italic>Trypanosoma cruzi<\/italic> clonal genotypes","volume":"47","author":"MJ Toledo","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.44.1.150-155.2000","article-title":"Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite <italic>Trypanosoma (Schizotrypanum) cruzi<\/italic> in immunocompetent and immunosuppressed murine hosts","volume":"44","author":"J Molina","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease","volume":"1","author":"JA Urbina","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref8","first-page":"82","article-title":"Chemotherapeutically effective nitro compounds. 3rd communication: nitropyridines, nitroimidazopyridines and related compounds","volume":"27","author":"E Winkelmann","year":"1977","journal-title":"Arzneimittelforschung"},{"key":"ref9","first-page":"679","article-title":"Metranidazole. A therapeutic review and update","volume":"54","author":"CD Freeman","year":"1997","journal-title":"Drugs"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.00749-08","article-title":"New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development","volume":"53","author":"J Van den Boogaard","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole \u2013 A new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"E Torreele","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/00034983.1983.11811668","article-title":"The activity of Fexinidazole (HOE 239) against experimental infections with <italic>Trypanosoma cruzi<\/italic>, trichomonads and <italic>Entamoeba histolytica<\/italic>","volume":"77","author":"W Raether","year":"1983","journal-title":"Ann Trop Med Parasitol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1590\/S0074-02762010000700014","article-title":"<italic>Trypanosoma cruzi<\/italic> Benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease","volume":"105","author":"M Moreno","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of <italic>Trypanosoma cruzi<\/italic> strains to drugs used clinically in Chagas disease","volume":"81","author":"LS Filardi","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1590\/S0074-02762011000600001","article-title":"Chronic Phase of Chagas Disease: Why should it be treated? A comprehensive review. Mem. Inst","volume":"106","author":"JR Coura","year":"2011","journal-title":"Oswaldo Cruz"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S0037-86821985000100010","article-title":"Reuni\u00e3o de Pesquisa Aplicada em Doen\u00e7a de Chagas: Validade do conceito de Forma Indeterminada","volume":"18","year":"1985","journal-title":"Ver Bras Med Trop"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.exppara.2007.08.016","article-title":"<italic>Trypanosoma cruzi<\/italic>: acute and long-term infection in the vertebrate host can modify the response to Benznidazole","volume":"118","author":"S Caldas","year":"2008","journal-title":"Exp Parasitol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/expr.1998.4191","article-title":"<italic>Trypanosoma cruzi<\/italic>: optimization of polymerase chain reaction for detection in human blood","volume":"88","author":"ML Gomes","year":"1998","journal-title":"Exp Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0166-6851(90)90160-N","article-title":"Schizodeme analysis of <italic>Trypanosoma cruzi<\/italic> stocks from South and Central America by analysis of PCR-amplified minicircle variable region sequences","volume":"42","author":"H Avila","year":"1990","journal-title":"Mol Biochem Parasitol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(03)00093-8","article-title":"Rapid quantitation of <italic>Trypanosoma cruzi<\/italic> in host tissue by real-time PCR","volume":"129","author":"KL Cummings","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref21","first-page":"55","article-title":"Enzyme immunoassays in diagnostic medicine. Theory and practice","volume":"53","author":"A Voller","year":"1976","journal-title":"Bull World Health Organ"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.archoralbio.2004.01.004","article-title":"Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp","volume":"49","author":"KL Maltos","year":"2004","journal-title":"Arch Oral Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/QCO.0b013e32833f9fd0","article-title":"Potential new drugs for human African trypanosomiasis: some progress at last","volume":"23","author":"MP Barrett","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0020-7519(02)00023-1","article-title":"<italic>Trypanosoma cruzi<\/italic> reinfections in mice determine the severity of cardiac damage","volume":"32","author":"JM Bustamante","year":"2002","journal-title":"Int J Parasitol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00436-008-0992-6","article-title":"Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions","volume":"103","author":"IS Caldas","year":"2008","journal-title":"Parasitol Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with Benznidazole during the chronic phase of experimental Chagas&apos; disease decreases cardiac alterations","volume":"49","author":"S Garcia","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/AAC.00332-10","article-title":"Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis","volume":"54","author":"AY Sokolova","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","article-title":"Genotoxicity profile of fexinidazole\u2014a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)","author":"D Tweats","year":"2012","journal-title":"Mutagenesis 2012"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:59:05Z","timestamp":1589032745000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001870"}},"subtitle":[],"editor":[{"given":"Michael P.","family":"Pollastri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001870","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}